Par Pharmaceutical Companies to Report Fourth Quarter and Full Year 2009 Results on February 24, 2010
2010年2月3日 - 7:27AM
PRニュース・ワイアー (英語)
WOODCLIFF LAKE, N.J., Feb. 2 /PRNewswire-FirstCall/ -- Par
Pharmaceutical Companies, Inc. (NYSE:PRX) announced today that it
will host a conference call and live webcast on Wednesday, February
24, 2010 at 8:30 am EST to review results for the fourth quarter
and full year ended December 31, 2009. Par will release its
financial results on February 24 before the market opens. Access to
the live webcast can be made via the Company's website at
http://www.parpharm.com/. Dial-in Information -------------------
Domestic: 866-770-7129 International: 617-213-8067 Passcode:
49930027 A replay of the conference call will be available for two
weeks approximately one hour after the call. Replay Information
------------------ Domestic: 866-286-8010 International:
617-801-6888 Passcode: 90488345 About Par Par Pharmaceutical
Companies, Inc. is a US-based specialty pharmaceutical company.
Through its wholly-owned subsidiary's two operating divisions, Par
Pharmaceutical and Strativa Pharmaceuticals, it develops,
manufactures and markets high barrier-to-entry generic drugs and
niche, innovative proprietary pharmaceuticals. For press release
and other company information, visit http://www.parpharm.com/.
DATASOURCE: Par Pharmaceutical Companies, Inc. CONTACT: Allison
Wey, Senior Director, Investor Relations and Corporate Affairs, Par
Pharmaceutical Companies, Inc., +1-201-802-4000 Web Site:
http://www.parpharm.com/
Copyright